Author:
Nicholls David J.,Wiley Katherine,Dainty Ian,MacIntosh Fraser,Phillips Caroline,Gaw Alasdair,Mårdh Carina Kärrman
Publisher
American Society for Pharmacology & Experimental Therapeutics (ASPET)
Subject
Pharmacology,Molecular Medicine
Reference44 articles.
1. Allen P, Bennion C, Cheshire DR, Cox RJ, Gaw A, Grime K, Meghani P, Nicholls D, Preston C, and Stonehouse JP (2014) The discovery of AZD5069; a CXCR2 antagonist in Phase II clinical trials for the treatment of asthma. EFMC-ISMC 2014 XXIII International Symposium on Medicinal Chemistry; 2014 Sept 11; Lisbon, Portugal.
2. International Union of Basic and Clinical Pharmacology. LXXXIX. Update on the Extended Family of Chemokine Receptors and Introducing a New Nomenclature for Atypical Chemokine Receptors
3. Chemokine expression in IBD. Mucosal chemokine expression is unselectively increased in both ulcerative colitis and Crohn's disease
4. New molecular targets for the treatment of neutrophilic diseases
5. Neutrophil Chemotactic Activity of Sputum From Patients With COPD
Cited by
76 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献